Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma

Author：                                          

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.2, Iss.3, 2011-01, pp. : 399-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 6, 2011-07 ,pp. : 560-575

Bentham Science Publishers

Access to resources Recommend Favorite

Type 1 Protein Tyrosine Kinases in Breast Carcinoma: A Review

By Suo Zhenhe   Nesland Jahn M.  

Ultrastructural Pathology, Vol. 26, Iss. 3, 2002-05 ,pp. : 125-135

Informa Healthcare

Access to resources Recommend Favorite

Receptor tyrosine kinases and the regulation of hematopoiesis

By Paulson R.F.   Bernstein A.  

Seminars in Immunology, Vol. 7, Iss. 4, 1995-04 ,pp. : 267-277

Academic Press

Access to resources Recommend Favorite

Expression of receptor tyrosine kinases in esophageal carcinosarcoma

By                                    

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2119-2126

Spandidos Publications

Access to resources Recommend Favorite

Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions

By Givant-Horwitz V.   Davidson B.   Lazarovici P.   Schaefer E.   Nesland J.M.   Trope C.G.   Reich R.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 160-172

Elsevier

Access to resources Recommend Favorite